Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIPD of Vancomycin in Critically Ill Children
NCT04666948Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2020
- Primary completion
- Dec 2023
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Gram-positive bacterial infection, sponsored by Ghent University Hospital. Started Dec 2020; status: completed.
02
Drugs
vancomycin
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT04666948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04666948.